Navigation Links
Research teams at Hebrew University, University of Kentucky win Israel-US science award
Date:5/23/2011

Jerusalem, May 23, 2011 -- Research teams at the University of Kentucky and the Hebrew University of Jerusalem have won a prestigious $300,000 award from the USIsrael Binational Science Foundation (BSF) for a new program devoted to transformative science

The BSF defines transformative science as "research driven by ideas that have potential to radically change our understanding of an important scientific concept, or lead to the creation of a new paradigm, or a new field of science. Such research is also characterized by its challenge to current understanding or by its pathways to new frontiers."

A collaborative research proposal entitled "Regulation of alternative splicing by small non-coding RNAs," was submitted by the groups of Prof. Ruth Sperling of the Alexander Silberman Institute of Life Sciences at the Hebrew University and Prof. Stefan Stamm at the University of Kentucky in Lexington. This was one of two programs awarded in the first round of the US-Israel BSF Transformative Science award.

The collaborative research aims to investigate how organisms regulate the readout of their genomic information. It is currently not known how the genetic information, stored in DNA, is interpreted to allow the formation of an organism.

The team will investigate the role of a new class of short forms of ribonucleic acids (RNA) molecules that are directly made from DNA, the molecule that stores the genomic information. They will investigate the role of these molecules that are expressed only in the nucleus of cells in controlling and coordinating the expression of genetic information in a biological meaningful way.

The group will concentrate on a brain receptor that controls appetite and food uptake. The assumption is that small RNA molecules are the master controllers that determine what genes are used.

This new concept could change the current thinking that gene expression is mainly dictated by regulatory proteins, and open the way to study the role of small non-coding RNAs in nuclear gene regulation.

This work could help to understand how the information in the genome is used to build an organism. It will be useful to design therapies against human diseases, for example to design drugs that suppress appetite. The verification of this assumption would open a new chapter in molecular biology.


'/>"/>

Contact: Jerry Barach
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Related biology news :

1. UCSB scientists make strides in vision research
2. Better buildings for extreme climates will be focus of researchers talk
3. DFG establishes 18 new research training groups
4. Top Australian malaria researcher elected Fellow of the Royal Society
5. Research ship Polarstern returns from Antartica
6. Researchers create nanopatch for the heart
7. UF research aims to help preserve plants, animals caught between forest fragments
8. Penn research answers long-standing question about swimming in elastic liquids
9. NTU receives $250,000 gift to promote groundbreaking research in sustainability
10. Prometheus Research Ranked #3 in 13th Annual ICIC and Fortune Magazines Inner City 100
11. Reforestation research in Latin America helps build better forests
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research teams at Hebrew University, University of Kentucky win Israel-US science award 
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... Calif. (PRWEB) , ... February 24, 2017 , ... Chef ... and wine scene. Making stops in several cities, she gained a number of ... adventure began in Stellenbosch, a town in South Africa’s Western Cape province. It ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
Breaking Biology Technology: